PDS Biotechnology
PDSB
PDSB
76 hedge funds and large institutions have $16.1M invested in PDS Biotechnology in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
36% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 25
47% less capital invested
Capital invested by funds: $30.1M → $16.1M (-$14.1M)
Holders
76
Holding in Top 10
–
Calls
$827K
Puts
$255K
Top Buyers
| 1 | +$1.12M | |
| 2 | +$665K | |
| 3 | +$240K | |
| 4 |
AGM
Alpine Global Management
New York
|
+$220K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$146K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$1.41M | |
| 3 | -$1.25M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$809K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$524K |